相似文献
1
Modeling human brain tumors in mice.
Brain Pathol. 2009 Jan;19(1):108-11. doi: 10.1111/j.1750-3639.2008.00232.x.
2
Applications of mouse glioma models in preclinical trials.
Mutat Res. 2005 Aug 25;576(1-2):54-65. doi: 10.1016/j.mrfmmm.2004.08.023.
3
[Adult diffuse glioma: genetic heterogeneity and therapeutic implications].
Med Sci (Paris). 2012 Oct;28(10):813-6. doi: 10.1051/medsci/20122810005. Epub 2012 Oct 12.
4
Molecular and cellular pathology of intrinsic brain tumours.
Cancer Metastasis Rev. 1997 Jun;16(1-2):155-77. doi: 10.1023/a:1005760726850.
5
On high-risk, low-grade glioma: What distinguishes high from low?
Cancer. 2019 Jan 15;125(2):174-176. doi: 10.1002/cncr.31834. Epub 2018 Dec 4.
6
Radio-responsive TRAIL gene therapy for malignant gliomas.
Cancer Gene Ther. 2007 Dec;14(12):1002. doi: 10.1038/sj.cgt.7701083. Epub 2007 Aug 17.
7
Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma.
Acta Neuropathol Commun. 2017 May 15;5(1):38. doi: 10.1186/s40478-017-0440-x.
8
Emerging role of new transgenic mouse models in glioma research.
Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S7-13. doi: 10.1586/14737140.7.12s.S7.
9
Glioma models.
Biochim Biophys Acta. 2001 Aug 31;1551(1):M19-27. doi: 10.1016/s0304-419x(01)00027-0.
10
[Therapy of malignant brain tumors by using apoptosis].
No To Shinkei. 1995 Sep;47(9):829-34.
引用本文的文献
1
Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
Discov Med. 2010 Oct;10(53):293-304.
本文引用的文献
1
Glioma stem cells: a midterm exam.
Neuron. 2008 Jun 26;58(6):832-46. doi: 10.1016/j.neuron.2008.05.031.
2
Brain tumor stem cells: bringing order to the chaos of brain cancer.
J Clin Oncol. 2008 Jun 10;26(17):2916-24. doi: 10.1200/JCO.2008.17.6792.
3
Cytokine regulation networks in the cancer microenvironment.
Front Biosci. 2008 May 1;13:6255-68. doi: 10.2741/3152.
4
Brain tumor stem cells and the tumor microenvironmen.
Neurosurg Focus. 2008;24(3-4):E27. doi: 10.3171/FOC/2008/24/3-4/E26.
5
Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
PLoS Med. 2008 Jan 22;5(1):e8. doi: 10.1371/journal.pmed.0050008.
6
Cancer stem cells and brain tumors: uprooting the bad seeds.
Expert Rev Anticancer Ther. 2007 Nov;7(11):1581-90. doi: 10.1586/14737140.7.11.1581.
7
Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93. doi: 10.1093/jnci/djm187. Epub 2007 Oct 30.
8
Where lies the blame for resistance--tumor or host?
Nat Med. 2007 Oct;13(10):1144-5. doi: 10.1038/nm1007-1144.
9
Cancer stem cells in radiation resistance.
Cancer Res. 2007 Oct 1;67(19):8980-4. doi: 10.1158/0008-5472.CAN-07-0895.
10
Making a tumour's bed: glioblastoma stem cells and the vascular niche.
Nat Rev Cancer. 2007 Oct;7(10):733-6. doi: 10.1038/nrc2246.
Zotero 插件